Developmental vitamin D3 deficiency induces alterations in immune organ morphology and function in adult offspring

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 239-242

  Harvey, Louise ^a,c   Burne, Thomas H J ^a,b   McGrath, John J ^a,b   Eyles, Darryl W ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^c DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Development; Immunology; Vitamin D3

Indexed keywords

COLECALCIFEROL; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL VITAMIN D3 DEFICIENCY; FEMALE; IMMUNE SYSTEM; IMMUNITY; LYMPHOCYTE; MALE; MORPHOLOGY; NONHUMAN; ORGAN SIZE; PHENOTYPE; PREGNANCY; PROGENY; RAT; VITAMIN D DEFICIENCY; ANIMAL; AUTOIMMUNE DISEASE; BIOLOGICAL MODEL; CYTOLOGY; DISEASE MODEL; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MONONUCLEAR CELL; REVIEW; SPRAGUE DAWLEY RAT; TH1 CELL;

RATTUS;

ANIMALS; AUTOIMMUNE DISEASES; CHOLECALCIFEROL; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNE SYSTEM; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MODELS, BIOLOGICAL; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; TH1 CELLS; VITAMIN D DEFICIENCY;

EID: 77954761521     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.050     Document Type: Article

References (33)

1. Hayes C.E., Nashold F.E., Spach K.M., Pedersen L.B. The immunological functions of the vitamin D endocrine system. Cell Mol. Biol. (Noisy-le-grand) 2003, 49(2):277-300.
2. Cantorna M.T. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol. 2006, 92(1):60-64.
3. Provvedini D.M., Tsoukas C.D., Deftos L.J., Manolagas S.C. 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 1983, 221(4616):1181-1183.
4. Deluca H.F., Cantorna M.T. Vitamin D: its role and uses in immunology. FASEB J. 2001, 15(14):2579-2585.
5. Lemire J.M., Adams J.S., Kermani-Arab V., Bakke A.C., Sakai R., Jordan S.C. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J. Immunol. 1985, 134(5):3032-3035.
6. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357(3):266-281.
7. McGrath J. Does 'imprinting' with low prenatal vitamin D contribute to the risk of various adult disorders?. Med. Hypotheses 2001, 56(3):367-371.
8. Hypponen E., Laara E., Reunanen A., Jarvelin M.R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358(9292):1500-1503.
9. Wientroub S., Winter C.C., Wahl S.M., Wahl L.M. Effect of vitamin D deficiency on macrophage and lymphocyte function in the rat. Calcif. Tissue Int. 1989, 44(2):125-130.
10. Eyles D., Brown J., Mackay-Sim A., McGrath J., Feron F. Vitamin D3 and brain development. Neuroscience 2003, 118(3):641-653.
11. O'Loan J., Eyles D.W., Kesby J., Ko P., McGrath J.J., Burne T.H. Vitamin D deficiency during various stages of pregnancy in the rat; its impact on development and behaviour in adult offspring. Psychoneuroendocrinology 2007, 32(3):227-234.
12. Looker A.C., Dawson-Hughes B., Calvo M.S., Gunter E.W., Sahyoun N.R. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002, 30(5):771-777.
13. Hillman L.S., Haddad J.G. Perinatal vitamin D metabolism. III. Factors influencing late gestational human serum 25-hydroxyvitamin D. Am. J. Obstet. Gynecol. 1976, 125(2):196-200.
14. Markestad T., Ulstein M., Bassoe H.H., Aksnes L., Aarskog D. Vitamin D metabolism in normal and hypoparathyroid pregnancy and lactation. Case report. Br. J. Obstet. Gynaecol. 1983, 90(10):971-976.
15. Reinhardt T.A., Horst R.L., Orf J.W., Hollis B.W. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J. Clin. Endocrinol. Metab. 1984, 58(1):91-98.
16. Morris D.L., Komocsar W.J. Immunophenotyping analysis of peripheral blood, splenic, and thymic lymphocytes in male and female rats. J. Pharmacol. Toxicol. Methods 1997, 37(1):37-46.
17. Alvarado C.S., Straus S.E., Li S., Dale J.K., Mann K., Le A., Lauer S.J. Autoimmune lymphoproliferative syndrome: a cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children-report on diagnosis and management of five patients. Pediatr. Blood Cancer 2004, 43(2):164-169.
18. Mitchell H.S., Johnson F. Ultra-violet radiations in conditions of extreme calcium and phosphorus deficiency. Am. J. Physiol. 1925, 72:143-150.
19. Mohamed M.I., Beckman M.J., Meehan J., DeLuca H.F. Effect of 1,25-dihydroxyvitamin D3 on mouse thymus: role of extracellular calcium. Biochim. Biophys. Acta 1996, 1289(2):275-283.
20. van Buul-Offers S.C., de Haan K., Reijnen-Gresnigt M.G., Meinsma D., Jansen M., Oei S.L., Bonte E.J., Sussenbach J.S., Van den Brande J.L. Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus. J. Endocrinol. 1995, 144(3):491-502.
21. Vink-van Wijngaarden T., Pols H.A., Buurman C.J., Birkenhager J.C., van Leeuwen J.P. Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089. Eur. J. Cancer 1996, 32A(5):842-848.
22. Croft M. Activation of naive, memory and effector T cells. Curr. Opin. Immunol. 1994, 6(3):431-437.
23. Tsoukas C.D., Provvedini D.M., Manolagas S.C. 1,25-Dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984, 224(4656):1438-1440.
24. Rigby W.F., Shen L., Ball E.D., Guyre P.M., Fanger M.W. Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis. Blood 1984, 64(5):1110-1115.
25. Bemiss C.J., Mahon B.D., Henry A., Weaver V., Cantorna M.T. Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in the immune system. Arch. Biochem. Biophys. 2002, 402(2):249-254.
26. Cantorna M.T., Hayes C.E., DeLuca H.F. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 1996, 93(15):7861-7864.
27. Cantorna M.T. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence?. Proc. Soc. Exp. Biol. Med. 2000, 223(3):230-233.
28. Atkinson M.A., Leiter E.H. The NOD mouse model of type 1 diabetes: as good as it gets?. Nat. Med. 1999, 5(6):601-604.
29. Ponsonby A.L., Lucas R.M., van der Mei I.A. UVR, vitamin D and three autoimmune diseases-multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem. Photobiol. 2005, 81(6):1267-1275.
30. Boonstra A., Barrat F.J., Crain C., Heath V.L., Savelkoul H.F., O'Garra A. 1alpha,25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol. 2001, 167(9):4974-4980.
31. McGrath J. Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia?. Schizophr. Res. 1999, 40(3):173-177.
32. Hypponen E., Sovio U., Wjst M., Patel S., Pekkanen J., Hartikainen A.L., Jarvelinb M.R. Infant vitamin D supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann. N.Y. Acad. Sci. 2004, 1037:84-95.
33. Giulietti A., Gysemans C., Stoffels K., van Etten E., Decallonne B., Overbergh L., Bouillon R., Mathieu C. Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 2004, 47(3):451-462.